Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?

BACKGROUND: As emphasized by international recommendations and largely confirmed by clinical experience, long-acting bronchodilators play a central role in the maintenance treatment of chronic obstructive pulmonary disease (COPD) due to their proven efficacy in reducing airflow obstruction and impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Blasi, F., Canonica, G. W., Miravitlles, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242048/
https://www.ncbi.nlm.nih.gov/pubmed/28100244
http://dx.doi.org/10.1186/s12931-017-0506-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242048/
https://www.ncbi.nlm.nih.gov/pubmed/28100244
http://dx.doi.org/10.1186/s12931-017-0506-0

Ejemplares similares